| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥21.54 |
| 52 Week High | CN¥42.15 |
| 52 Week Low | CN¥17.83 |
| Beta | 0.16 |
| 1 Month Change | -11.54% |
| 3 Month Change | -19.96% |
| 1 Year Change | -30.70% |
| 3 Year Change | -61.88% |
| 5 Year Change | n/a |
| Change since IPO | -46.07% |
Recent News & Updates
Shareholder Returns
| 300937 | CN Consumer Retailing | CN Market | |
|---|---|---|---|
| 7D | -1.2% | 0.01% | -0.4% |
| 1Y | -30.7% | -20.5% | -14.4% |
Return vs Industry: 300937 underperformed the CN Consumer Retailing industry which returned -20.5% over the past year.
Return vs Market: 300937 underperformed the CN Market which returned -14.4% over the past year.
Price Volatility
| 300937 volatility | |
|---|---|
| 300937 Average Weekly Movement | 8.5% |
| Consumer Retailing Industry Average Movement | 7.5% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 300937's share price has been volatile over the past 3 months.
Volatility Over Time: 300937's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 1,114 | Shunjun Chen | www.hezongyy.com |
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. distributes generic drugs and Chinese medicines in China. The company offers medications in the areas of respiratory, anti-inflammatory, five senses, skin and external, digestive, hepatobiliary system, rehabilitation and tranquility, women, pediatrics, cardiovascular and neurological, endocrine system, rheumatoid bone injury, and others.
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. Fundamentals Summary
| 300937 fundamental statistics | |
|---|---|
| Market cap | CN¥2.06b |
| Earnings (TTM) | CN¥37.12m |
| Revenue (TTM) | CN¥4.55b |
55.5x
P/E Ratio0.5x
P/S RatioIs 300937 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300937 income statement (TTM) | |
|---|---|
| Revenue | CN¥4.55b |
| Cost of Revenue | CN¥4.21b |
| Gross Profit | CN¥340.06m |
| Other Expenses | CN¥302.94m |
| Earnings | CN¥37.12m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.39 |
| Gross Margin | 7.48% |
| Net Profit Margin | 0.82% |
| Debt/Equity Ratio | 48.6% |
How did 300937 perform over the long term?
See historical performance and comparison